293 related articles for article (PubMed ID: 29271882)
1. Potent and Selective Carboxylic Acid Inhibitors of Tumor-Associated Carbonic Anhydrases IX and XII.
Cau Y; Vullo D; Mori M; Dreassi E; Supuran CT; Botta M
Molecules; 2017 Dec; 23(1):. PubMed ID: 29271882
[TBL] [Abstract][Full Text] [Related]
2. New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies.
Carradori S; Mollica A; Ceruso M; D'Ascenzio M; De Monte C; Chimenti P; Sabia R; Akdemir A; Supuran CT
Bioorg Med Chem; 2015 Jul; 23(13):2975-81. PubMed ID: 26007302
[TBL] [Abstract][Full Text] [Related]
3. Discovery of first-in-class multi-target adenosine A
Ceni C; Catarzi D; Varano F; Ben DD; Marucci G; Buccioni M; Volpini R; Angeli A; Nocentini A; Gratteri P; Supuran CT; Colotta V
Eur J Med Chem; 2020 Sep; 201():112478. PubMed ID: 32659606
[TBL] [Abstract][Full Text] [Related]
4. N-β-glycosyl sulfamides are selective inhibitors of the cancer associated carbonic anhydrase isoforms IX and XII.
Rodríguez OM; Maresca A; Témpera CA; Bravo RD; Colinas PA; Supuran CT
Bioorg Med Chem Lett; 2011 Aug; 21(15):4447-50. PubMed ID: 21723123
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT
Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519
[TBL] [Abstract][Full Text] [Related]
6. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors.
Thacker PS; Alvala M; Arifuddin M; Angeli A; Supuran CT
Bioorg Chem; 2019 May; 86():386-392. PubMed ID: 30763885
[TBL] [Abstract][Full Text] [Related]
8. Pyrazolylbenzo[d]imidazoles as new potent and selective inhibitors of carbonic anhydrase isoforms hCA IX and XII.
Kumar S; Ceruso M; Tuccinardi T; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2907-2913. PubMed ID: 27166574
[TBL] [Abstract][Full Text] [Related]
9. Virtual screening, molecular dynamics, and binding free energy calculations on human carbonic anhydrase IX catalytic domain for deciphering potential leads.
John A; Sivashanmugam M; Umashankar V; Natarajan SK
J Biomol Struct Dyn; 2017 Aug; 35(10):2155-2168. PubMed ID: 27373313
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones.
Sarikaya B; Ceruso M; Carta F; Supuran CT
Bioorg Med Chem; 2014 Nov; 22(21):5883-90. PubMed ID: 25267005
[TBL] [Abstract][Full Text] [Related]
11. 4-Functionalized 1,3-diarylpyrazoles bearing 6-aminosulfonylbenzothiazole moiety as potent inhibitors of carbonic anhydrase isoforms hCA I, II, IX and XII.
SitaRam ; Ceruso M; Khloya P; Supuran CT; Sharma PK
Bioorg Med Chem; 2014 Dec; 22(24):6945-52. PubMed ID: 25456084
[TBL] [Abstract][Full Text] [Related]
12. Extending the Inhibition Profiles of Coumarin-Based Compounds Against Human Carbonic Anhydrases: Synthesis, Biological, and In Silico Evaluation.
Kartsev V; Geronikaki A; Bua S; Nocentini A; Petrou A; Lichitsky B; Frasinyuk M; Leitans J; Kazaks A; Tars K; Supuran CT
Molecules; 2019 Oct; 24(19):. PubMed ID: 31590289
[TBL] [Abstract][Full Text] [Related]
13. Computational investigation of the selectivity of salen and tetrahydrosalen compounds towards the tumor-associated hCA XII isozyme.
Akdemir A; De Monte C; Carradori S; Supuran CT
J Enzyme Inhib Med Chem; 2015 Feb; 30(1):114-8. PubMed ID: 24666302
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
[TBL] [Abstract][Full Text] [Related]
15. Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.
Mollica A; Costante R; Akdemir A; Carradori S; Stefanucci A; Macedonio G; Ceruso M; Supuran CT
Bioorg Med Chem; 2015 Sep; 23(17):5311-8. PubMed ID: 26264840
[TBL] [Abstract][Full Text] [Related]
16. Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII.
Chandak N; Ceruso M; Supuran CT; Sharma PK
Bioorg Med Chem; 2016 Jul; 24(13):2882-2886. PubMed ID: 27137360
[TBL] [Abstract][Full Text] [Related]
17. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII.
Nocentini A; Carta F; Ceruso M; Bartolucci G; Supuran CT
Bioorg Med Chem; 2015 Nov; 23(21):6955-66. PubMed ID: 26432607
[TBL] [Abstract][Full Text] [Related]
18. o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII.
Güzel-Akdemir Ö; Akdemir A; Isik S; Vullo D; Supuran CT
Bioorg Med Chem; 2013 Mar; 21(6):1386-91. PubMed ID: 23352754
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of novel 4,7-disubstituted coumarins as selective tumor-associated carbonic anhydrase IX and XII inhibitors.
Chandra KM; Goud NS; Arifuddin M; Alvala M; Alvala R; Angeli A; Supuran CT
Bioorg Med Chem Lett; 2021 May; 39():127877. PubMed ID: 33640442
[TBL] [Abstract][Full Text] [Related]
20. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
